摘要
2018年,我国西药类产品的进出口总额达632.87亿美元,同比2017年下降8.83%。其中,出口额为368.83亿美元,同比2017年增长4.03%,继续保持了良好的增长态势;进口额为264.04亿美元,同比2017年下降22.26%,这主要是因为近期我国为了保障百姓用药的可及性和可负担性而采取了一系列降低药价的政策措施,在政策合力的影响下,进口药价显著降低,惠及民生。
In 2018, the total import and export volume of pharmaceuticals in China reached US $ 63. 387 billion, a year-on-year decrease of 8. 83%. Among them, the export value was US $ 36. 683 billion, an increase of 4. 03% year-on-year, and continued to maintain a good growth trend;the import value was US $ 26. 404 billion, down 22. 26 % year-on-year, This was mainly because China has recently adopted a series of policy measures to reduce drug prices in order to ensure the access and affordability of drugs for the common people. Under the influence of policy synergy, the price of imported drugs has finally been significantly reduced, benefiting people's livelihood.
作者
荣嫡
RONG Di(China Chamber of Commerce for Import and Export of Medicines and Health Products,Beijing 100010, China)
出处
《精细与专用化学品》
CAS
2019年第7期1-3,共3页
Fine and Specialty Chemicals
关键词
西药
进口
出口
pharmaceuticals
import
export
